Cathie Wood's ARK ETFs have disclosed their daily ... Additionally, ARK bought 78,752 shares of 10X Genomics Inc (NASDAQ:TXG) for a total of $1,122,216, reinforcing the fund's focus on life ...

Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the life science tools and diagnostics group to be down ...

Try Now>> See the top stocks recommended by analysts >> Read More on TXG: 10x Genomics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...

10x Genomics Price Performance Shares of TXG opened at $12.31 on Tuesday. The firm has a market cap of $1.49 billion, a PE ratio of -8.05 and a beta of 1.85. The stock’s fifty day moving average ...

Leerink Partners lowered 10x Genomics from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $25.00 to $12.00 in a research report on Thursday.

Indeed, if you’re a younger investor who’s tech-savvy, you’ll probably be more sold on Cathie Wood’s funds. Whether you’re a believer in Bitcoin, AI-powered genomics, the robotaxi ...

PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology ...

Cathie Wood's portfolio at Ark Invest holds a number of speculative stocks. One company in Ark's portfolio showing signs of maturity is fintech stock SoFi Technologies. Despite its impressive ...

Tesla (TSLA) bull Cathie Wood is sticking with the electric vehicle maker after a rough February. The Ark Investment founder says there is a lot of "pent-up demand" for Tesla vehicles. The big ...